Press Release
New Market Intelligence Report Reveals $15B Opportunity in Chronic Cough Therapeutics, With Zero FDA-Approved Competitors
Comprehensive Chronic Cough Report reveals $15B opportunity. 100M patients, zero FDA-approved drugs, positioning digital cough monitoring as essential pharma infrastructure.